| # | Drug | Count |
|---|---|---|
| 0 | TESTOSTERONE | 20 |
| 1 | PACLITAXEL | 8 |
| 2 | PACLITAXEL (AIBUMIN-BOUND) | 8 |
| 3 | CARBOPLATIN | 7 |
| 4 | ADALIMUMAB | 6 |
| 5 | BEVACIZUMAB | 6 |
| 6 | TACROLIMUS | 6 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 8 | TACROLIMUS OINTMENT 0.1% | 6 |
| 9 | CISPLATIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOSTARLIMAB | 3 | 0.0012 |
| 1 | TISOTUMAB VEDOTIN | 1 | 0.0010 |
| 2 | TESTOSTERONE | 20 | 0.0008 |
| 3 | TESTOSTERONE UNDECANOATE | 1 | 0.0005 |
| 4 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 5 | MITOMYCIN | 1 | 0.0003 |
| 6 | ROMIPLOSTIM | 2 | 0.0001 |
| 7 | SELINEXOR | 1 | 0.0001 |
| 8 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 9 | MISOPROSTOL | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Androgen [EPC] | 20 |
| 1 | Platinum-based Drug [EPC] | 12 |
| 2 | Corticosteroid [EPC] | 8 |
| 3 | Microtubule Inhibitor [EPC] | 8 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 |
| 5 | Atypical Antipsychotic [EPC] | 5 |
| 6 | Benzodiazepine [EPC] | 4 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 4 |
| 8 | Insulin Analog [EPC] | 2 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen [EPC] | 20 | 0.0007 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 2 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 8 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 12 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 | 0.0000 |
| 7 | Potassium Channel Blocker [EPC] | 1 | 0.0000 |
| 8 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 5 | 0.0000 |